{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:23:50Z","timestamp":1772749430400,"version":"3.50.1"},"reference-count":49,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cardiometabolic Synd"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p>Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of HIV\u2010positive patients. However, long\u2010term adverse effects of this therapy include dyslipidemia, insulin resistance (IR), changes in body fat distribution (lipodystrophy), and cardiometabolic syndrome (CMS). IR in HIV\u2010positive patients does not seem to represent a significant independent risk factor for the development of cardiovascular disease; nevertheless, the association with other metabolic complications (dyslipidemia, fat redistribution) and CMS may increase the risk of type 2 diabetes and cardiovascular disease. The use of nucleoside analogue reverse transcriptase inhibitors is associated with the development of upper trunk and visceral fat accumulation and may cause IR. The progression of IR toward diabetes may be impeded with the choice of HAART regimens with less IR effects and encouraging patients to adhere to a healthy lifestyle. For patients with marked IR but relatively preserved fat, the use of metformin may consent the improvement of CMS and lipodystrophy, especially when combined with an appropriate exercise program. Therapy with rosiglitazone is not indicated in these patients.<\/jats:p>","DOI":"10.1111\/j.1559-4572.2008.00027.x","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T05:01:49Z","timestamp":1232514109000},"page":"40-43","source":"Crossref","is-referenced-by-count":14,"title":["Insulin Resistance and the Cardiometabolic Syndrome in HIV Infection"],"prefix":"10.1111","volume":"4","author":[{"given":"Maurizio","family":"Bevilacqua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia J.","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,20]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0919"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.7.1177"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.06.001"},{"key":"e_1_2_10_5_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/135965350601100413","article-title":"Incidence of and risk factors for insulin resistance in treatment\u2010naive HIV\u2010infected patients 48 weeks after starting highly active antiretroviral therapy","volume":"11","author":"Palacios R","year":"2006","journal-title":"Antivir Ther"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/317541"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31814b94e2"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.032"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1075"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318074ef83"},{"issue":"2","key":"e_1_2_10_11_2","first-page":"3S","article-title":"Epidemiology of diabetes mellitus and associated cardiovascular risk factors: focus on human immunodeficiency virus and psychiatric disorders","volume":"118","author":"Zimmet P","year":"2005","journal-title":"Am J Med"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-006-0037-1"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907090-00001"},{"key":"e_1_2_10_14_2","first-page":"5","article-title":"HIV\u2010associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution","volume":"12","author":"Balasubramanyam A","year":"2006","journal-title":"Res Initiat Treat Action"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60293-0"},{"key":"e_1_2_10_16_2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long\u2010term nucleoside analogue therapy","volume":"13","author":"Saint\u2010Marc T","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910220-00035"},{"key":"e_1_2_10_18_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint\u2010Marc T","year":"2000","journal-title":"AIDS"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350300800614"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1071\/SH04058"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528120-00002"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.5.679"},{"key":"e_1_2_10_23_2","first-page":"191","article-title":"Switching strategies to improve lipid profile and morphologic changes","volume":"8","author":"Barragan P","year":"2006","journal-title":"AIDS Rev"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00711.x"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200502000-00005"},{"key":"e_1_2_10_26_2","first-page":"34","article-title":"The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome","volume":"9","author":"Nolan D","year":"2004","journal-title":"J HIV Ther"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1310\/hct0805-345"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350701200407"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00550.2006"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/496981"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31804216cf"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-007-0019-4"},{"key":"e_1_2_10_33_2","first-page":"3","article-title":"Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy","volume":"9","author":"Mallon PW","year":"2007","journal-title":"AIDS Rev"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183629.20041.bb"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-6295-5"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1157\/13085017"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki165"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2006.07.002"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.472"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002967.pub2"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/375850"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70440-6"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00488.x"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1086\/518005"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008712"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1086\/422144"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200211080-00012"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1559-4564.2006.06104.x"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/79.5.820"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280d3587f"}],"container-title":["Journal of the CardioMetabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1559-4572.2008.00027.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1559-4572.2008.00027.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:21:16Z","timestamp":1697433676000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1559-4572.2008.00027.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1559-4572.2008.00027.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1559-4572.2008.00027.x","archive":["Portico"],"relation":{},"ISSN":["1559-4564","1559-4572"],"issn-type":[{"value":"1559-4564","type":"print"},{"value":"1559-4572","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,20]]}}}